John Hughman talks to Megan Boxall and James Norrington about whether the tech share sell-off could spell trouble for the wider market, and a potential wave of consolidation coming to the pharmaceutical industry. Plus the latest small-cap gems unearthed by Simon Thompson.
Create your
podcast in
minutes
It is Free